IFNA2 and COVID-19: Among COVID-19 patients for which daily viral RNA measurements were available, those with neutralizing IFN-α2 Abs had a longer time to viral clearance from the respiratory tract patients without (median 24 days vs 34 days, HR 2.3, 95% CI 1.2–4.4, Fig. 1C).